Reduction of venous cannulation pain by use of volatile anesthetic agents

Comparative evaluation of volatile anesthetic agents for attenuation of venous cannulation pain: A prospective, randomized controlled study

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2016/04/006880

Enrollment

120

Registered

2016-04-27

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- ASA grade I or III patient, Non diabetic planeed for venous cannulation

Interventions

Intervention1: Halothane: Halothane 1 ml middle of the volar surface of the forearm Intervention2: Isoflurane: Isoflurane 1.5 ml middle of the volar surface of the forearm Intervention3: Sevoflurane:

Eligibility

Inclusion criteria

Inclusion criteria: ASA grade I and III

Exclusion criteria

Exclusion criteria: 1.Patients with known sensitivity to study drugs 2.Subjects allergic to cotton or adhesive dressing, metal or plastic 3.History of acute or chronic pain or daily intake of analgesics 4.Calcium channel blocker or beta blocker within one month of recruiting 5.Abnormal skin conditions such as infection at the site of proposed venous cannulation 6.Cold hypersensitivity 7.Psychiatric patients

Design outcomes

Primary

Measure	Time frame
incidence of venous cannulation painTimepoint: At the time of venous cannulation	—

Secondary

Measure	Time frame
Severity of pain by VAS (0-100) and complication of cannulationTimepoint: At the time of cannulation and after cannulation	—

Countries

India

Contacts

Public ContactDr Vinit Kumar Srivastava

Apollo Hospitals Bilaspur

drvinit75@gmail.com9755557539

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026